NEW ORLEANS – Screen patients with epilepsy for psychiatric comorbidities.
NEW ORLEANS – As much as 8% of patients with pediatric epilepsy may have moderately severe depressive symptoms, and...
The highest-risk AEDs were zonisamide, rufinamide, clorazepate, lamotrigine, carbamazepine, and phenytoin.
ATLANTA – Susan Schneider Williams shares “three overlooked ideas in this disease space.”
The agency’s approval of Dsuvia comes at a time when the need is great for nonaddictive agents for pain control.
The opioid is to used for only adult patients in settings that are closely controlled.
Topics include: Short-term NSAID use • chronic liver disease & pneumonia • Antibiotic prescribing • fractures in older men • ART for younger...
News from the FDA/CDC
The central nervous system depressant was approved for the treatment of cataplexy and excessive daytime sleepiness.
SAN DIEGO – Vascular disease, especially of the small blood vessels, may be a culprit.
ATLANTA – The prolonged period of heightened risk was evident in patients with both STEMI and NSTEMI.